CytomX Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CytomX Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • CytomX Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $5.74M, a 91.7% increase year-over-year.
  • CytomX Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $13.8M.
  • CytomX Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$569K, a 99.4% increase from 2022.
  • CytomX Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$99.3M, a 14.3% increase from 2021.
  • CytomX Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$116M, a 78.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.8M $5.74M +$2.74M +91.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $11.1M -$6.53M -$5.45M -501% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 $16.5M $13.8M +$17.1M Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$569K $837K +$9.61M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$10.2M $2.99M +$32.1M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$42.2M -$1.09M +$28.4M +96.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$70.6M -$3.31M +$28.7M +89.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$99.3M -$8.78M +$26M +74.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$125M -$29.1M +$1.92M +6.19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$127M -$29.5M -$2.76M -10.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$125M -$32M -$8.65M -37.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$116M -$34.8M -$10.8M -45.1% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-27
Q3 2021 -$105M -$31M -$5.95M -23.8% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-03-27
Q2 2021 -$99.1M -$26.7M -$1.44M -5.68% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-03-27
Q1 2021 -$97.7M -$23.3M -$32.8M -345% Jan 1, 2021 Mar 31, 2021 10-K/A 2023-03-27
Q4 2020 -$64.8M -$24M +$11.5M +32.3% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-27
Q3 2020 -$76.3M -$25M -$1.33M -5.63% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-03-27
Q2 2020 -$74.9M -$25.3M +$3.66M +12.6% Apr 1, 2020 Jun 30, 2020 10-K/A 2023-03-27
Q1 2020 -$78.6M $9.51M +$23.6M Jan 1, 2020 Mar 31, 2020 10-K/A 2023-03-27
Q4 2019 -$102M -$35.5M -$3.22M -10% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-27
Q3 2019 -$99M -$23.7M -$268K -1.14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$98.7M -$29M -$15.5M -115% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$83.2M -$14.1M +$1.37M +8.84% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$84.6M -$32.2M -$32.9M -5290% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$51.8M -$23.4M -$13.2M -129% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$38.6M -$13.4M +$11.8M +46.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$50.3M -$15.5M -$7.24M -87.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$43.1M $621K +$14.7M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$57.8M -$10.2M +$4.42M +30.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$62.2M -$25.2M -$11M -77.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$51.1M -$8.26M +$7.77M +48.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$58.9M -$14M -$2.55M -22.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$56.4M -$14.7M -$2.79M -23.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$53.6M -$14.2M -$8.37M -144% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$45.2M -$16M -$9.82M -158% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$35.4M -$11.5M -$6.7M -140% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$28.7M -$11.9M -$8.28M -231% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$20.4M -$5.81M -$876K -17.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$19.5M -$6.21M +$10.8M +63.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$30.3M -$4.79M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-07
Q3 2014 -$3.59M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-07
Q2 2014 -$4.93M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-07
Q1 2014 -$17M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.